Reviva Pharmaceuticals Ownership | Who Owns Reviva Pharmaceuticals?


OverviewForecastChart

Reviva Pharmaceuticals Ownership Summary


Reviva Pharmaceuticals is owned by 22.87% institutional investors, 14.34% insiders, and 62.78% retail investors. Millennium management is the largest institutional shareholder, holding 5.34% of RVPH shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.62% of its assets in Reviva Pharmaceuticals shares.

RVPH Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockReviva Pharmaceuticals22.87%14.34%62.78%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Millennium management1.80M5.34%$3.27M
Vanguard group1.38M4.10%$2.51M
Armistice capital1.36M4.04%$2.47M
Schonfeld strategic advisors1.06M3.13%$1.92M
Parkman healthcare partners514.27K1.52%$930.83K
Geode capital management311.70K0.92%$564.28K
Susquehanna group, llp202.01K0.60%$365.64K
Tang capital management170.00K0.50%$307.70K
Blackrock102.93K0.43%$131.75K
Blackrock funding, inc. /de115.10K0.34%$208.33K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Parkman healthcare partners514.27K0.12%$930.83K
Emc capital management44.53K0.05%$81.00K
Armistice capital1.36M0.03%$2.47M
Tang capital management170.00K0.02%$307.70K
Nri wealth management lc12.38K0.02%$22.41M
Schonfeld strategic advisors1.06M0.01%$1.92M
Drive wealth management20.00K0.01%$36.20K
Xtx topco25.02K0.00%$45.29K
Pale fire capital se25.00K0.00%$32.00K
Sound income strategies30.00K0.00%$54.30K

Top Buyers

HolderShares% AssetsChange
Vanguard group1.38M-359.34K
Tang capital management170.00K0.02%170.00K
Susquehanna group, llp202.01K0.00%138.84K
Ameriprise financial46.47K-46.47K
Engineers gate manager lp34.58K0.00%34.58K

Top Sellers

HolderShares% AssetsChange
Armistice capital1.36M0.03%-1.82M
Woodline partners lp---684.80K
Schonfeld strategic advisors1.06M0.01%-457.80K
Sabby management---237.00K
Polar asset management partners---154.80K

New Positions

HolderShares% AssetsChangeValue
Tang capital management170.00K0.02%170.00K$307.70K
Ameriprise financial46.47K-46.47K$84.11K
Engineers gate manager lp34.58K0.00%34.58K$62.59K
Xtx topco25.02K0.00%25.02K$45.29K
Drive wealth management20.00K0.01%20.00K$36.20K

Sold Out

HolderChange
Qube research-50.00
Wells fargo & company/mn-175.00
Advisor group-250.00
Archer investment-500.00
Godsey & gibb-1.10K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 20244932.43%7,732,309-22.27%222.64%30100.00%8-11.11%
Sep 30, 2024375.71%9,947,22745.22%415.10%15-25.00%980.00%
Jun 30, 2024356.06%6,849,68722.89%285.30%2025.00%5-16.67%
Mar 31, 202433-28.26%5,573,8375.84%234.83%16-42.86%6-14.29%
Dec 31, 20234615.00%5,266,25697.73%2115.55%2847.37%7-22.22%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv1.22M2.62%158.43K
Vanguard US Total Market Shares ETF700.44K1.50%-
Vanguard Institutional Extnd Mkt Idx Tr407.78K0.88%-
Fidelity Extended Market Index162.31K0.35%-1.03K
BlackRock Extended Equity Market K48.10K0.15%-20.00
iShares Micro-Cap ETF52.13K0.11%-
NT Ext Equity Mkt Idx Fd - L48.87K0.10%14.74K
Extended Equity Market Fund K47.59K0.10%146.00
Fidelity Total Market Index46.94K0.10%-
Fidelity Series Total Market Index38.55K0.08%3.79K

Recent Insider Transactions


DateNameRoleActivityValue
Nov 18, 2022Patel Purav-Buy$14.07K
Sep 30, 2022Narayan Prabhu Chief Financial OfficerBuy$83.00K
Sep 08, 2022VEDANTA PARTNERS, LLC-Buy$86.96
Sep 08, 2022VEDANTA PARTNERS, LLC-Buy$51.38
Sep 08, 2022VEDANTA PARTNERS, LLC-Buy$2.09M

Insider Transactions Trends


DateBuySell
2024 Q4--
2024 Q3--
2023 Q4--
2023 Q2--
2022 Q41-

RVPH Ownership FAQ


Who Owns Reviva Pharmaceuticals?

Reviva Pharmaceuticals shareholders are primarily institutional investors at 22.87%, followed by 14.34% insiders and 62.79% retail investors. The average institutional ownership in Reviva Pharmaceuticals's industry, Biotech Stocks , is 68.48%, which Reviva Pharmaceuticals falls below.

Who owns the most shares of Reviva Pharmaceuticals?

Reviva Pharmaceuticals’s largest shareholders are Millennium management (1.8M shares, 5.34%), Vanguard group (1.38M shares, 4.10%), and Armistice capital (1.36M shares, 4.04%). Together, they hold 13.47% of Reviva Pharmaceuticals’s total shares outstanding.

Does Blackrock own Reviva Pharmaceuticals?

Yes, BlackRock owns 0.43% of Reviva Pharmaceuticals, totaling 102.93K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 131.75K$. In the last quarter, BlackRock increased its holdings by 11.07K shares, a 12.05% change.

Who is Reviva Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Parkman healthcare partners is Reviva Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 0.12% of its assets in 514.27K Reviva Pharmaceuticals shares, valued at 930.83K$.

Who is the top mutual fund holder of Reviva Pharmaceuticals shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Reviva Pharmaceuticals shares, with 2.62% of its total shares outstanding invested in 1.22M Reviva Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools